{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T08:21:35Z","timestamp":1717402895832},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Facial Plastic Surgery Clinics of North America"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.fsc.2012.11.007","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T17:43:34Z","timestamp":1359481414000},"page":"33-42","source":"Crossref","is-referenced-by-count":21,"title":["Melanoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Adam","family":"Ingraffea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.fsc.2012.11.007_bib1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1586\/era.10.170","article-title":"A\u00a0new understanding in the epidemiology of melanoma","volume":"10","author":"Erdei","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.fsc.2012.11.007_bib2","unstructured":"Melanoma. National Cancer Institute. Available at: http:\/\/www.cancer.gov\/cancertopics\/types\/melanoma. Accessed September 17, 2012."},{"key":"10.1016\/j.fsc.2012.11.007_bib3","unstructured":"Melanoma. Available at: http:\/\/nci.nih.gov\/aboutnci\/servingpeople\/snapshots\/melanoma.pdf. Accessed August 24, 2012."},{"key":"10.1016\/j.fsc.2012.11.007_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/93.9.678","article-title":"Recent trends in melanoma incidence among whites in the United States","volume":"93","author":"Jemal","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.fsc.2012.11.007_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archderm.141.4.477","article-title":"Association of UV index, latitude, and melanoma incidence in nonwhite populations: US Surveillance, Epidemiology, and End Results (SEER) Program, 1992-2001","volume":"141","author":"Eide","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib6","unstructured":"Melanoma. Available at: http:\/\/www.cdc.gov\/cancer\/dcpc\/research\/articles\/melanoma_supplement.htm. Accessed March 19, 2012."},{"issue":"12","key":"10.1016\/j.fsc.2012.11.007_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archdermatol.2009.302","article-title":"Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida","volume":"145","author":"Hu","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaad.2006.12.028","article-title":"Association between the anatomic distribution of melanoma and sex","volume":"56","author":"Clark","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ije\/dyp166","article-title":"Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls","volume":"38","author":"Chang","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.fsc.2012.11.007_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.fsc.2012.11.007_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jcb.23402","article-title":"Immunotherapy for metastatic melanoma","volume":"113","author":"Zito","year":"2012","journal-title":"J\u00a0Cell Biochem"},{"issue":"4","key":"10.1016\/j.fsc.2012.11.007_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","article-title":"Focus on melanoma","volume":"2","author":"Houghton","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.fsc.2012.11.007_bib13","series-title":"Textbook of melanoma","author":"Thompson","year":"2004"},{"key":"10.1016\/j.fsc.2012.11.007_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/92.12.1006","article-title":"Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations","volume":"92","author":"Goldstein","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.fsc.2012.11.007_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.fsc.2012.11.007_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molonc.2011.03.002","article-title":"Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care","volume":"5","author":"Scolyer","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.fsc.2012.11.007_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yadr.2007.07.009","article-title":"Genetic mutations involved in melanoma: a summary of our current understanding","volume":"23","author":"High","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib18","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","article-title":"The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm","volume":"130","author":"Kraemer","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium","volume":"91","author":"Easton","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.fsc.2012.11.007_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-4632.2010.04381.x","article-title":"Defining the patient at high risk for melanoma","volume":"49","author":"Psaty","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.294.13.1647","article-title":"Clinicopathological features of and risk factors for multiple primary melanomas","volume":"294","author":"Ferrone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.fsc.2012.11.007_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mjd.2001.110878","article-title":"Multiple primary melanomas","volume":"44","author":"Stam-Postguna","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib23","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fsc.2012.11.007_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1747.2003.12041.x","article-title":"Familial and attributable risks in cutaneous melanoma: effects of proband and age","volume":"120","author":"Hemminki","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"issue":"23","key":"10.1016\/j.fsc.2012.11.007_bib25","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/jnci\/djn389","article-title":"Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control","volume":"100","author":"Jemal","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fsc.2012.11.007_bib26","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/bjc.1996.642","article-title":"Non-Hodgkin\u2019s lymphomas, chronic lymphocytic leukaemias and skin cancers","volume":"74","author":"Levi","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fsc.2012.11.007_bib27","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.fsc.2012.11.007_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1751-1097.2012.01077.x","article-title":"Geographical variation in residence and risk of multiple non-melanoma skin cancers in US women and men","volume":"88","author":"Wei-Passanese","year":"2012","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.fsc.2012.11.007_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.02.010","article-title":"Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma\/Skin Cancer Screening program experience 2001-2005","volume":"57","author":"Goldberg","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2008.10.065","article-title":"Strategies for early melanoma detection: approaches to the patient with nevi","volume":"60","author":"Goodson","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/ijc.22453","article-title":"The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review","volume":"120","author":"The International Agency for Research on Cancer Working Group on Artificial Ultraviolet (UV) Light, Skin Cancer","year":"2007","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.fsc.2012.11.007_bib32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/ijc.24011","article-title":"Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis","volume":"124","author":"Olsen","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fsc.2012.11.007_bib33","series-title":"Cutaneous melanoma","first-page":"60","article-title":"The dysplastic nevus as precursor and marker of increased risk for melanoma","author":"Albert","year":"1992"},{"issue":"3","key":"10.1016\/j.fsc.2012.11.007_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clindermatol.2010.04.004","article-title":"Congenital melanocytic nevi: when to worry and how to treat. Facts and controversies","volume":"28","author":"Price","year":"2010","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.fsc.2012.11.007_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clindermatol.2010.12.002","article-title":"Dermatoscopy: an overview of subsurface morphology","volume":"29","author":"Hirokawa","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib36","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/cncr.25148","article-title":"Prognostic factors in cutaneous desmoplatic melanoma: a study of 252 patient","volume":"116","author":"Murali","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.fsc.2012.11.007_bib37","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.23895","article-title":"Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases","volume":"113","author":"Chen","year":"2008","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.fsc.2012.11.007_bib38","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.fsc.2012.11.007_bib39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","article-title":"Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology","volume":"65","author":"Bichakjian","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.fsc.2012.11.007_bib40","first-page":"S87","article-title":"Reducing mortality in individuals at high risk for advanced melanoma through education and screening","volume":"65","author":"Geller","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib41","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1002\/cncr.26707","article-title":"Behavioral determinants of successful early melanoma detection: role of self and physician skin examination","volume":"118","author":"Swetter","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.fsc.2012.11.007_bib42","first-page":"419","article-title":"Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis","volume":"46","author":"Haigh","year":"2003","journal-title":"Can J Surg"},{"key":"10.1016\/j.fsc.2012.11.007_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.fsc.2012.11.007_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03178777","article-title":"Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor","volume":"26","author":"Fukada","year":"2003","journal-title":"Australas Phys Eng Sci Med"},{"issue":"Suppl 1","key":"10.1016\/j.fsc.2012.11.007_bib45","first-page":"S11","article-title":"High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long term survival update","volume":"6","author":"Atkins","year":"2000","journal-title":"Cancer J Sci Am"},{"issue":"6","key":"10.1016\/j.fsc.2012.11.007_bib46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.clindermatol.2008.09.020","article-title":"Chemotherapy and biologic therapies for melanoma: do they work?","volume":"27","author":"Jilaveanu","year":"2009","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.fsc.2012.11.007_bib47","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1158\/1078-0432.CCR-08-2663","article-title":"Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial","volume":"15","author":"Davis","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.fsc.2012.11.007_bib48","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/mt.2010.49","article-title":"A\u00a0fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21R alpha chain with immune activating and tumoricidal effects in\u00a0vivo","volume":"18","author":"Williams","year":"2010","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.fsc.2012.11.007_bib49","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.4049\/jimmunol.154.11.5851","article-title":"Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha","volume":"154","author":"Szabolcs","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.fsc.2012.11.007_bib50","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.8504","article-title":"E4697: Phase III cooperative group study of yeast-derived granulocyte macrophage colony-stimulating factor (GM-CSF) versus placebo as adjuvant treatment of patients with completely resected stage III-IV melanoma","volume":"28","author":"Lawson","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"35","key":"10.1016\/j.fsc.2012.11.007_bib51","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1200\/JCO.2005.02.5791","article-title":"Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma","volume":"23","author":"Weber","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.fsc.2012.11.007_bib52","first-page":"381","article-title":"Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma","volume":"84","author":"Mansh","year":"2011","journal-title":"Yale J Biol Med"},{"issue":"26","key":"10.1016\/j.fsc.2012.11.007_bib53","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.fsc.2012.11.007_bib54","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2008.26.15_suppl.lba9011","article-title":"Phase III, open-label, randomized, comparative study of tremelimumab (CP-675,206) and chemotherapy (temozolomide [TMZ] or dacarbazine [DTIC]) in patients with advanced melanoma","volume":"26","author":"Ribas","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.fsc.2012.11.007_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1200\/JCO.2011.37.5394","article-title":"Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma","volume":"30","author":"Tarhini","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.fsc.2012.11.007_bib56","unstructured":"MelaFind. Available at: http:\/\/www.melasciences.com. Accessed July 2, 2012."},{"issue":"2","key":"10.1016\/j.fsc.2012.11.007_bib57","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archdermatol.2010.302","article-title":"The performance of MelaFind: a prospective multicenter study","volume":"147","author":"Monheit","year":"2011","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.fsc.2012.11.007_bib58","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archderm.144.4.476","article-title":"The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas","volume":"144","author":"Friedman","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.fsc.2012.11.007_bib59","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1158\/1078-0432.CCR-08-1231","article-title":"Immunogenicity and antitumor effects of vaccination with peptide vaccine\u00a0+\/-granulocyte-monocyte colonocyte stimulating factor and\/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696","volume":"15","author":"Kirwood","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.fsc.2012.11.007_bib60","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.181.1.776","article-title":"Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant","volume":"181","author":"Adams","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.fsc.2012.11.007_bib61","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1158\/0008-5472.CAN-10-3988","article-title":"TLR4 engagement during TLR3-induced pro-inflammatory signaling in dendritic cells promotes IL-10-mediated suppression of anti-tumor immunity","volume":"71","author":"Bogunovic","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.fsc.2012.11.007_bib62","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.1999.17.10.3245","article-title":"Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium","volume":"17","author":"Kefford","year":"1999","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Facial Plastic Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740612001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740612001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T08:14:30Z","timestamp":1714896870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064740612001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1064740612001538"],"URL":"https:\/\/doi.org\/10.1016\/j.fsc.2012.11.007","relation":{},"ISSN":["1064-7406"],"issn-type":[{"value":"1064-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}